Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by AKIN GUMP STRAUSS HAUER & FELD.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
$120,000.00
Expenses
Not reported
Filing UUID
27970887-d822-4d4e-8572-bc57bd523202
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to budget reconciliation; Issues related to Most Favored Nation pricing proposals; Issues related drug pricing.

TRD · Trade (domestic/foreign)

Issues related to IP protection; Issues related to market access; Issues related to PhRMA Section 232 tariffs.

CPT · Copyright/Patent/Trademark

Issues related to patent reform legislation; Issues related to H.R. 3160/S. 1553 - PREVAIL Act.

Literal federal measure citations: H.R. 3160, S. 1553

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.